Agreed! I think it was important that the Q1 report confirmed the $47M PO from Pedima, so now getting a confirmation that the 1st batch of GenViro kits was delivered will tie the two together, which will mean that Pharma Tech will receive a healthy payment for Release PO #1.
And, 3 weeks after that...Release PO #2.
(2)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links